Quantitative Impact of Human Immunodeficiency Virus Infection on Tuberculosis Dynamics

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2007 Aug 11

PMID 17690336

Citations 16

Authors

Kathryn DeRiemer

L Masae Kawamura

Philip C Hopewell

Charles L Daley

Affiliations

Soon will be listed here.

Abstract

Rationale: Human immunodeficiency virus (HIV) infection has a major but unquantified impact on the risk of tuberculosis.

Objectives: To quantify the impact of HIV infection on the number of tuberculosis cases in San Francisco.

Methods: We studied all patients reported with tuberculosis in San Francisco from 1991 to 2002. The initial isolates of Mycobacterium tuberculosis were genotyped using IS6110 restriction fragment-length polymorphism genotyping as the primary method, and clustered cases (identical genotype patterns) were identified.

Measurements And Main Results: We determined the case number, case rate, and the fraction of tuberculosis attributable to HIV infection. Of 2,991 reported tuberculosis cases, 2,193 (73.3%) had a genotype pattern of M. tuberculosis available. Genotypic clusters with at least one HIV-positive person were larger, lasted longer, and had a shorter time between successive cases relative to clusters with only HIV-uninfected persons (P < 0.00005, P = 0.0009, P = 0.018, respectively). Overall, 13.7% of the tuberculosis cases were attributable to HIV infection and an estimated 405 excess tuberculosis cases occurred.

Conclusions: During a period encompassing the resurgence and decline of tuberculosis in San Francisco, a substantial number of the tuberculosis cases were attributable to HIV infection. Coinfection with HIV amplified the local tuberculosis epidemic.

Citing Articles

Global, regional, and national burden of HIV and tuberculosis and predictions by Bayesian age-period-cohort analysis: a systematic analysis for the global burden of disease study 2021.

Tian X, Wang C, Hao Z, Chen J, Wu N Front Reprod Health. 2024; 6:1475498.

PMID: 39720120 PMC: 11666487. DOI: 10.3389/frph.2024.1475498.

HIV co-infection is associated with reduced Mycobacterium tuberculosis transmissibility in sub-Saharan Africa.

Windels E, Wampande E, Joloba M, Boom W, Goig G, Cox H PLoS Pathog. 2024; 20(5):e1011675.

PMID: 38696531 PMC: 11093396. DOI: 10.1371/journal.ppat.1011675.

Sensitivity and specificity of tuberculosis signs and symptoms screening and adjunct role of social pathology characteristics in predicting bacteriologically confirmed tuberculosis in Myanmar.

Htet K, Chongsuvivatwong V, Aung S Trop Med Health. 2021; 49(1):3.

PMID: 33407932 PMC: 7789670. DOI: 10.1186/s41182-020-00292-x.

Types and prevalence of HIV-related opportunistic infections/conditions among HIV-positive patients attending Kenyatta National Hospital in Nairobi, Kenya.

Chepkondol G, Jolly P, Yatich N, Mbowe O, Jaoko W Afr Health Sci. 2020; 20(2):615-624.

PMID: 33163022 PMC: 7609085. DOI: 10.4314/ahs.v20i2.9.

Mycobacterium tuberculosis Reactivates HIV-1 via Exosome-Mediated Resetting of Cellular Redox Potential and Bioenergetics.

Tyagi P, Pal V, Agrawal R, Singh S, Srinivasan S, Singh A mBio. 2020; 11(2).

PMID: 32127457 PMC: 7064780. DOI: 10.1128/mBio.03293-19.

References

Lawn S, Badri M, Wood R . Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS. 2005; 19(18):2109-16. DOI: 10.1097/01.aids.0000194808.20035.c1. View

. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med. 2005; 172(9):1169-227. DOI: 10.1164/rccm.2508001. View

Crampin A, Glynn J, Traore H, Yates M, Mwaungulu L, Mwenebabu M . Tuberculosis transmission attributable to close contacts and HIV status, Malawi. Emerg Infect Dis. 2006; 12(5):729-35. PMC: 3374426. DOI: 10.3201/eid1205.050789. View

Wood R, Middelkoop K, Myer L, Grant A, Whitelaw A, Lawn S . Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med. 2006; 175(1):87-93. PMC: 1899262. DOI: 10.1164/rccm.200606-759OC. View

Corbett E, Bandason T, Cheung Y, Munyati S, Godfrey-Faussett P, Hayes R . Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med. 2007; 4(1):e22. PMC: 1761052. DOI: 10.1371/journal.pmed.0040022. View

Antonucci G, Girardi E, Raviglione M, Ippolito G . Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA. 1995; 274(2):143-8. DOI: 10.1001/jama.274.2.143. View

Fine P, BRUCE J, Ponnighaus J, Nkhosa P, Harawa A, Vynnycky E . Tuberculin sensitivity: conversions and reversions in a rural African population. Int J Tuberc Lung Dis. 1999; 3(11):962-75. View

Whalen C, Nsubuga P, Okwera A, Johnson J, Hom D, Michael N . Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS. 2000; 14(9):1219-28. PMC: 2869086. DOI: 10.1097/00002030-200006160-00020. View

Cruciani M, Malena M, Bosco O, Gatti G, Serpelloni G . The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis. Clin Infect Dis. 2001; 33(11):1922-30. DOI: 10.1086/324352. View

10.

Porco T, Small P, Blower S . Amplification dynamics: predicting the effect of HIV on tuberculosis outbreaks. J Acquir Immune Defic Syndr. 2001; 28(5):437-44. DOI: 10.1097/00042560-200112150-00005. View

11.

Carvalho A, DeRiemer K, Nunes Z, Martins M, Comelli M, Marinoni A . Transmission of Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis patients. Am J Respir Crit Care Med. 2001; 164(12):2166-71. DOI: 10.1164/ajrccm.164.12.2103078. View

12.

Santoro-Lopes G, de Pinho A, Harrison L, Schechter M . Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. Clin Infect Dis. 2002; 34(4):543-6. DOI: 10.1086/338641. View

13.

Murray M, Alland D . Methodological problems in the molecular epidemiology of tuberculosis. Am J Epidemiol. 2002; 155(6):565-71. DOI: 10.1093/aje/155.6.565. View

14.

Badri M, Wilson D, Wood R . Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet. 2002; 359(9323):2059-64. DOI: 10.1016/S0140-6736(02)08904-3. View

15.

Godfrey-Faussett P, Maher D, Mukadi Y, Nunn P, Perriens J, Raviglione M . How human immunodeficiency virus voluntary testing can contribute to tuberculosis control. Bull World Health Organ. 2003; 80(12):939-45. PMC: 2567701. View

16.

Corbett E, Watt C, Walker N, Maher D, Williams B, Raviglione M . The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003; 163(9):1009-21. DOI: 10.1001/archinte.163.9.1009. View

17.

Williams B, Dye C . Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science. 2003; 301(5639):1535-7. DOI: 10.1126/science.1086845. View

18.

Currie C, Williams B, Cheng R, Dye C . Tuberculosis epidemics driven by HIV: is prevention better than cure?. AIDS. 2003; 17(17):2501-8. DOI: 10.1097/01.aids.0000096903.73209.ac. View

19.

Suggaravetsiri P, Yanai H, Chongsuvivatwong V, Naimpasan O, Akarasewi P . Integrated counseling and screening for tuberculosis and HIV among household contacts of tuberculosis patients in an endemic area of HIV infection: Chiang Rai, Thailand. Int J Tuberc Lung Dis. 2003; 7(12 Suppl 3):S424-31. View

20.

Reichler M, Bur S, Reves R, Mangura B, Thompson V, Ford J . Results of testing for human immunodeficiency virus infection among recent contacts of infectious tuberculosis cases in the United States. Int J Tuberc Lung Dis. 2003; 7(12 Suppl 3):S471-8. View